Specific lytic activity against mycobacterial antigens is inversely correlated with the severity of tuberculosis

被引:24
作者
De la Barrera, SS
Finiasz, M
Frias, A
Alemán, M
Barrionuevo, P
Fink, S
Franco, MC
Abbate, E
Sasiain, MD
机构
[1] Acad Nacl Med Buenos Aires, Inst Invest Hematol, Dept Inmunol, RA-1425 Buenos Aires, DF, Argentina
[2] Hosp FJ Muniz, Inst Vaccarezza, Buenos Aires, DF, Argentina
关键词
cytotoxicity; lymphocytes; tuberculosis;
D O I
10.1046/j.1365-2249.2003.02176.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ability of peripheral blood mononuclear cells (PBMC) from patients with active tuberculosis to display cytotoxic responses against autologous Mycobacterium tuberculosis (Mtb)-pulsed macrophages was evaluated. Non-MHC restricted cell-dependent lytic activity was observed in ex vivo effector cells from tuberculosis patients and was mediated mainly by CD3(+) gammadeltaTCR(+)T (gammadeltaT) cells bearing CD56 and/ or CD16 molecules MHC-restricted and non-NMC restricted cytotoxic T cells (CTL) were differentially expanded upon stimulation with Mtb in tuberculosis patients and normal controls (N). Class-I restricted CD8(+) CTL and class-II restricted CD4(+) CTL were generated in PPD+N and to a lesser extent in PPD-N. Mtb-stimulated effector cells from tuberculosis patients became progressively non-MHC restricted CD4(-)CD8(-) gammadeltaT cells, while lytic activity of CD4(+) and CD8(+)CTL decreased gradually as the disease became more severe. On the other hand, target cells were lysed by ex vivo cells from tuberculosis patients through the Fas-FasL and, perforin pathways. Mtb-induced CD4(+) CTL from tuberculosis patients and N controls preferentially employed the Fas-FasL mechanism. Mtb-induced CD8(+) CTL effector cells from patients used the perforin-based mechanism while cells from N controls also used the Fas-FasL pathway. While Mtb-induced gammadelta CTL from patients and PPD-N employed the latter mechanism cells from PPD+N individuals also used the perforin pathway. It can be concluded that shifts in the CTL response and the cytolytic mechanisms take place as the pulmonary involvement becomes more severe.
引用
收藏
页码:450 / 461
页数:12
相关论文
共 43 条
[31]  
Satoh M, 1996, J IMMUNOL, V157, P3886
[32]   HETEROGENEITY OF THE REPERTOIRE OF T-CELLS OF TUBERCULOSIS PATIENTS AND HEALTHY CONTACTS TO MYCOBACTERIUM-TUBERCULOSIS ANTIGENS SEPARATED BY HIGH-RESOLUTION TECHNIQUES [J].
SCHOEL, B ;
GULLE, H ;
KAUFMANN, SHE .
INFECTION AND IMMUNITY, 1992, 60 (04) :1717-1720
[33]   CD4+ T cells are required for the development of cytotoxic CD8+ T cells during Mycobacterium tuberculosis infection [J].
Serbina, NV ;
Lazarevic, V ;
Flynn, JL .
JOURNAL OF IMMUNOLOGY, 2001, 167 (12) :6991-7000
[34]   Human CD8+ T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia [J].
Smith, SM ;
Klein, MR ;
Malin, AS ;
Sillah, J ;
Huygen, K ;
Andersen, P ;
McAdam, KPWJ ;
Dockrell, HM .
INFECTION AND IMMUNITY, 2000, 68 (12) :7144-7148
[35]  
Stenger S, 1998, J IMMUNOL, V161, P3582
[36]   An antimicrobial activity of cytolytic T cells mediated by granulysin [J].
Stenger, S ;
Hanson, DA ;
Teitelbaum, R ;
Dewan, P ;
Niazi, KR ;
Froelich, CJ ;
Ganz, T ;
Thoma-Uszynski, S ;
Melián, A ;
Bogdan, C ;
Porcelli, SA ;
Bloom, BR ;
Krensky, AM ;
Modlin, RL .
SCIENCE, 1998, 282 (5386) :121-125
[37]   Differential effects of cytolytic T cell subsets on intracellular infection [J].
Stenger, S ;
Mazzaccaro, RJ ;
Uyemura, K ;
Cho, S ;
Barnes, PF ;
Rosat, JP ;
Sette, A ;
Brenner, MB ;
Porcelli, SA ;
Bloom, BR ;
Modlin, RL .
SCIENCE, 1997, 276 (5319) :1684-1687
[38]  
Tan JS, 1997, J IMMUNOL, V159, P290
[39]   NATURAL AND SYNTHETIC NONPEPTIDE ANTIGENS RECOGNIZED BY HUMAN GAMMA-DELTA T-CELLS [J].
TANAKA, Y ;
MORITA, CT ;
TANAKA, Y ;
NIEVES, E ;
BRENNER, MB ;
BLOOM, BR .
NATURE, 1995, 375 (6527) :155-158
[40]   CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis [J].
Thoma-Uszynski, S ;
Stenger, S ;
Modlin, RL .
JOURNAL OF IMMUNOLOGY, 2000, 165 (10) :5773-5779